Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-08-003765
Filing Date
2008-02-29
Accepted
2008-02-29 06:02:00
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f38446e10vk.htm 10-K 900143
2 EXHIBIT 23.1 f38446exv23w1.htm EX-23.1 10257
3 EXHIBIT 31.1 f38446exv31w1.htm EX-31.1 7447
4 EXHIBIT 31.2 f38446exv31w2.htm EX-31.2 7416
5 EXHIBIT 32.1 f38446exv32w1.htm EX-32.1 5791
6 GRAPHIC f38446f3844601.gif GRAPHIC 12308
  Complete submission text file 0000950134-08-003765.txt   949567
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 08652757
SIC: 2836 Biological Products, (No Diagnostic Substances)